Patient-perceived progression in multiple system atrophy: natural history of quality of life
Tiphaine Saulnier (BPH), Margherita Fabbri (CIC 1436, CHU Toulouse),, M\'elanie Le Goff, Catherine Helmer (BPH), Anne Pavy-Le Traon, Wassilios G., Meissner (IMN), Olivier Rascol (CIC 1436), C\'ecile Proust-Lima (BPH),, Alexandra Foubert-Samier (BPH, IMN)

TL;DR
This study characterizes the progression of health-related quality of life in multiple system atrophy patients over time, identifying key dimensions and items that inform patient care and disease management.
Contribution
It introduces a novel four-step statistical approach to analyze multidimensional quality of life data in MSA, revealing new insights into disease progression.
Findings
Four Hr-QoL dimensions identified, including a new oropharyngeal component.
Motor and oropharyngeal domains deteriorate rapidly, nonmotor and emotional domains decline slowly.
Impairments linked to sex, diagnosis subtype, and symptom onset delay.
Abstract
Health-related quality of life (Hr-QoL) scales provide crucial information on neurodegenerative disease progression, help improving patient care, and constitute a meaningful endpoint for therapeutic research. However, Hr-QoL progression is usually poorly documented, as for multiple system atrophy (MSA), a rare and rapidly progressing alpha-synucleinopathy. This work aimed to describe Hr-QoL progression during the natural course of MSA, explore disparities between patients, and identify informative items using a four-step statistical strategy.We leveraged the data of the French MSA cohort comprising annual assessments with the MSA-QoL questionnaire for more than 500 patients over up to 11 years. The four-step strategy (1) determined the subdimensions of Hr-QoL in MSA; (2) modelled the subdimension trajectories over time, accounting for the risk of death; (3) mapped the sequence of item…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsParkinson's Disease Mechanisms and Treatments · Neurological diseases and metabolism · Botulinum Toxin and Related Neurological Disorders
